Key result
Neonatal pulse oximetry screening detected 72% of severe congenital heart defects compared to 58% with clinical examination, reducing the likelihood of discharging infants with unknown CHD.
Why the study?
Does neonatal pulse oximetry screening improve the timely detection of congenital heart disease in newborns compared to clinical examination?
Systematic Review (n=44,969)
Does neonatal pulse oximetry screening improve the timely detection of congenital heart disease in newborns compared to clinical examination?
Absolute Event Rate: 72% vs 58%
Pulse oximetry screening, when used as an adjunct to clinical examination, improves the detection of congenital heart disease in newborns and reduces the risk of discharging infants with undiagnosed severe defects.
No takes yet. Share an insight, caveat, or question.
Supports routine pulse oximetry screening alongside clinical exam in newborns; confirms benefit in Level 1 evidence for timely severe CHD detection.
Pekka Valmari (2007) conducted a systematic review in Congenital heart disease (CHD) (n=44,969). Neonatal pulse oximetry (PO) screening vs. Clinical examination was evaluated on Detection of 15 individual severe congenital heart defects. Neonatal pulse oximetry screening detected 72% of severe congenital heart defects compared to 58% with clinical examination, reducing the likelihood of discharging infants with unknown CHD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: